Stay updated on Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial
Sign up to get notified when there's something new on the Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial page.

Latest updates to the Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial page
- Check5 days agoChange DetectedThe record now displays details for the Vyvanse study, including its purpose, eligibility criteria, treatment plan, outcomes, locations, and study dates, instead of a forbidden-access error.SummaryDifference38%

- Check12 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2, while the study page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA site-wide NIH notice appears above the study page, linking to transition updates and explaining that some NIH content may use “Super Intelligence” instead of “Artificial Intelligence.”SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check33 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check47 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the usual study content with a basic error view and standard site chrome.SummaryDifference0.5%

Stay in the know with updates to Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial page.